Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging
Key claim: Elamipretide rejuvenates oocyte quality and restores female fertility during reproductive aging.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Elamipretide (SS-31) is already in human trials for mitochondrial myopathy and age-related cardiac and visual phenotypes; extending it into oocyte quality adds the female germline to the list of tissues where a cardiolipin-binding peptide reportedly rescues age-related mitochondrial failure. The finding is preclinical, and the pitch of ‘restoring fertility’ is substantially ahead of any human reproductive-aging readout — the mechanism→intervention gap is the central caveat.